1 Medicine for Osteoarthritis Pain Market Overview 1.1 Product Overview and Scope of Medicine for Osteoarthritis Pain 1.2 Medicine for Osteoarthritis Pain Segment by Type 1.2.1 Global Medicine for Osteoarthritis Pain Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Oral 1.2.3 Injection 1.2.4 External 1.3 Medicine for Osteoarthritis Pain Segment by Application 1.3.1 Global Medicine for Osteoarthritis Pain Sales Comparison by Application: (2021-2027) 1.3.2 Medical Care 1.3.3 Personal Care 1.4 Global Medicine for Osteoarthritis Pain Market Size Estimates and Forecasts 1.4.1 Global Medicine for Osteoarthritis Pain Revenue 2016-2027 1.4.2 Global Medicine for Osteoarthritis Pain Sales 2016-2027 1.4.3 Medicine for Osteoarthritis Pain Market Size by Region: 2016 Versus 2021 Versus 2027 2 Medicine for Osteoarthritis Pain Market Competition by Manufacturers 2.1 Global Medicine for Osteoarthritis Pain Sales Market Share by Manufacturers (2016-2021) 2.2 Global Medicine for Osteoarthritis Pain Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Medicine for Osteoarthritis Pain Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Medicine for Osteoarthritis Pain Manufacturing Sites, Area Served, Product Type 2.5 Medicine for Osteoarthritis Pain Market Competitive Situation and Trends 2.5.1 Medicine for Osteoarthritis Pain Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Medicine for Osteoarthritis Pain Players Market Share by Revenue 2.5.3 Global Medicine for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Medicine for Osteoarthritis Pain Retrospective Market Scenario by Region 3.1 Global Medicine for Osteoarthritis Pain Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Medicine for Osteoarthritis Pain Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Medicine for Osteoarthritis Pain Market Facts & Figures by Country 3.3.1 North America Medicine for Osteoarthritis Pain Sales by Country 3.3.2 North America Medicine for Osteoarthritis Pain Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Medicine for Osteoarthritis Pain Market Facts & Figures by Country 3.4.1 Europe Medicine for Osteoarthritis Pain Sales by Country 3.4.2 Europe Medicine for Osteoarthritis Pain Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Medicine for Osteoarthritis Pain Market Facts & Figures by Region 3.5.1 Asia Pacific Medicine for Osteoarthritis Pain Sales by Region 3.5.2 Asia Pacific Medicine for Osteoarthritis Pain Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Medicine for Osteoarthritis Pain Market Facts & Figures by Country 3.6.1 Latin America Medicine for Osteoarthritis Pain Sales by Country 3.6.2 Latin America Medicine for Osteoarthritis Pain Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Medicine for Osteoarthritis Pain Market Facts & Figures by Country 3.7.1 Middle East and Africa Medicine for Osteoarthritis Pain Sales by Country 3.7.2 Middle East and Africa Medicine for Osteoarthritis Pain Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Medicine for Osteoarthritis Pain Historic Market Analysis by Type 4.1 Global Medicine for Osteoarthritis Pain Sales Market Share by Type (2016-2021) 4.2 Global Medicine for Osteoarthritis Pain Revenue Market Share by Type (2016-2021) 4.3 Global Medicine for Osteoarthritis Pain Price by Type (2016-2021) 5 Global Medicine for Osteoarthritis Pain Historic Market Analysis by Application 5.1 Global Medicine for Osteoarthritis Pain Sales Market Share by Application (2016-2021) 5.2 Global Medicine for Osteoarthritis Pain Revenue Market Share by Application (2016-2021) 5.3 Global Medicine for Osteoarthritis Pain Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Pfizer Medicine for Osteoarthritis Pain Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 Johnson and Johnson 6.2.1 Johnson and Johnson Corporation Information 6.2.2 Johnson and Johnson Description and Business Overview 6.2.3 Johnson and Johnson Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Johnson and Johnson Medicine for Osteoarthritis Pain Product Portfolio 6.2.5 Johnson and Johnson Recent Developments/Updates 6.3 GlaxoSmithKline 6.3.1 GlaxoSmithKline Corporation Information 6.3.2 GlaxoSmithKline Description and Business Overview 6.3.3 GlaxoSmithKline Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.3.4 GlaxoSmithKline Medicine for Osteoarthritis Pain Product Portfolio 6.3.5 GlaxoSmithKline Recent Developments/Updates 6.4 Bayer 6.4.1 Bayer Corporation Information 6.4.2 Bayer Description and Business Overview 6.4.3 Bayer Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Bayer Medicine for Osteoarthritis Pain Product Portfolio 6.4.5 Bayer Recent Developments/Updates 6.5 Eli Lilly 6.5.1 Eli Lilly Corporation Information 6.5.2 Eli Lilly Description and Business Overview 6.5.3 Eli Lilly Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Eli Lilly Medicine for Osteoarthritis Pain Product Portfolio 6.5.5 Eli Lilly Recent Developments/Updates 6.6 Novartis 6.6.1 Novartis Corporation Information 6.6.2 Novartis Description and Business Overview 6.6.3 Novartis Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Novartis Medicine for Osteoarthritis Pain Product Portfolio 6.6.5 Novartis Recent Developments/Updates 6.7 Sanofi 6.6.1 Sanofi Corporation Information 6.6.2 Sanofi Description and Business Overview 6.6.3 Sanofi Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sanofi Medicine for Osteoarthritis Pain Product Portfolio 6.7.5 Sanofi Recent Developments/Updates 6.8 Horizon Pharma 6.8.1 Horizon Pharma Corporation Information 6.8.2 Horizon Pharma Description and Business Overview 6.8.3 Horizon Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Horizon Pharma Medicine for Osteoarthritis Pain Product Portfolio 6.8.5 Horizon Pharma Recent Developments/Updates 6.9 Abbott 6.9.1 Abbott Corporation Information 6.9.2 Abbott Description and Business Overview 6.9.3 Abbott Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Abbott Medicine for Osteoarthritis Pain Product Portfolio 6.9.5 Abbott Recent Developments/Updates 6.10 Mylan 6.10.1 Mylan Corporation Information 6.10.2 Mylan Description and Business Overview 6.10.3 Mylan Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Mylan Medicine for Osteoarthritis Pain Product Portfolio 6.10.5 Mylan Recent Developments/Updates 6.11 Daiichi Sankyo 6.11.1 Daiichi Sankyo Corporation Information 6.11.2 Daiichi Sankyo Medicine for Osteoarthritis Pain Description and Business Overview 6.11.3 Daiichi Sankyo Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Daiichi Sankyo Medicine for Osteoarthritis Pain Product Portfolio 6.11.5 Daiichi Sankyo Recent Developments/Updates 6.12 TEVA 6.12.1 TEVA Corporation Information 6.12.2 TEVA Medicine for Osteoarthritis Pain Description and Business Overview 6.12.3 TEVA Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.12.4 TEVA Medicine for Osteoarthritis Pain Product Portfolio 6.12.5 TEVA Recent Developments/Updates 6.13 Almatica Pharma 6.13.1 Almatica Pharma Corporation Information 6.13.2 Almatica Pharma Medicine for Osteoarthritis Pain Description and Business Overview 6.13.3 Almatica Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Almatica Pharma Medicine for Osteoarthritis Pain Product Portfolio 6.13.5 Almatica Pharma Recent Developments/Updates 6.14 Astellas Pharma 6.14.1 Astellas Pharma Corporation Information 6.14.2 Astellas Pharma Medicine for Osteoarthritis Pain Description and Business Overview 6.14.3 Astellas Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.14.4 Astellas Pharma Medicine for Osteoarthritis Pain Product Portfolio 6.14.5 Astellas Pharma Recent Developments/Updates 6.15 Tide Pharmaceutical 6.15.1 Tide Pharmaceutical Corporation Information 6.15.2 Tide Pharmaceutical Medicine for Osteoarthritis Pain Description and Business Overview 6.15.3 Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.15.4 Tide Pharmaceutical Medicine for Osteoarthritis Pain Product Portfolio 6.15.5 Tide Pharmaceutical Recent Developments/Updates 6.16 Iroko Pharmaceuticals 6.16.1 Iroko Pharmaceuticals Corporation Information 6.16.2 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Description and Business Overview 6.16.3 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.16.4 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product Portfolio 6.16.5 Iroko Pharmaceuticals Recent Developments/Updates 6.17 Hengrui Pharmaceutical 6.17.1 Hengrui Pharmaceutical Corporation Information 6.17.2 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Description and Business Overview 6.17.3 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.17.4 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product Portfolio 6.17.5 Hengrui Pharmaceutical Recent Developments/Updates 6.18 Abiogen Pharma 6.18.1 Abiogen Pharma Corporation Information 6.18.2 Abiogen Pharma Medicine for Osteoarthritis Pain Description and Business Overview 6.18.3 Abiogen Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2016-2021) 6.18.4 Abiogen Pharma Medicine for Osteoarthritis Pain Product Portfolio 6.18.5 Abiogen Pharma Recent Developments/Updates 7 Medicine for Osteoarthritis Pain Manufacturing Cost Analysis 7.1 Medicine for Osteoarthritis Pain Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Medicine for Osteoarthritis Pain 7.4 Medicine for Osteoarthritis Pain Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Medicine for Osteoarthritis Pain Distributors List 8.3 Medicine for Osteoarthritis Pain Customers 9 Medicine for Osteoarthritis Pain Market Dynamics 9.1 Medicine for Osteoarthritis Pain Industry Trends 9.2 Medicine for Osteoarthritis Pain Growth Drivers 9.3 Medicine for Osteoarthritis Pain Market Challenges 9.4 Medicine for Osteoarthritis Pain Market Restraints 10 Global Market Forecast 10.1 Medicine for Osteoarthritis Pain Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Medicine for Osteoarthritis Pain by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Medicine for Osteoarthritis Pain by Type (2022-2027) 10.2 Medicine for Osteoarthritis Pain Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Medicine for Osteoarthritis Pain by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Medicine for Osteoarthritis Pain by Application (2022-2027) 10.3 Medicine for Osteoarthritis Pain Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Medicine for Osteoarthritis Pain by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Medicine for Osteoarthritis Pain by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Medicine for Osteoarthritis Pain Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Medicine for Osteoarthritis Pain Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Medicine for Osteoarthritis Pain Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Medicine for Osteoarthritis Pain Covered in This Study Table 5. Global Medicine for Osteoarthritis Pain Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Medicine for Osteoarthritis Pain Sales Market Share by Manufacturers (2016-2021) Table 7. Global Medicine for Osteoarthritis Pain Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Medicine for Osteoarthritis Pain Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Medicine for Osteoarthritis Pain Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Medicine for Osteoarthritis Pain Manufacturing Sites and Area Served Table 11. Manufacturers Medicine for Osteoarthritis Pain Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Medicine for Osteoarthritis Pain by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medicine for Osteoarthritis Pain as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Medicine for Osteoarthritis Pain Sales by Region (2016-2021) & (K Units) Table 16. Global Medicine for Osteoarthritis Pain Sales Market Share by Region (2016-2021) Table 17. Global Medicine for Osteoarthritis Pain Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Medicine for Osteoarthritis Pain Sales by Country (2016-2021) & (K Units) Table 19. North America Medicine for Osteoarthritis Pain Sales Market Share by Country (2016-2021) Table 20. North America Medicine for Osteoarthritis Pain Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Medicine for Osteoarthritis Pain Revenue Market Share by Country (2016-2021) Table 22. Europe Medicine for Osteoarthritis Pain Sales by Country (2016-2021) & (K Units) Table 23. Europe Medicine for Osteoarthritis Pain Sales Market Share by Country (2016-2021) Table 24. Europe Medicine for Osteoarthritis Pain Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Medicine for Osteoarthritis Pain Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Medicine for Osteoarthritis Pain Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Medicine for Osteoarthritis Pain Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Medicine for Osteoarthritis Pain Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Medicine for Osteoarthritis Pain Revenue Market Share by Region (2016-2021) Table 30. Latin America Medicine for Osteoarthritis Pain Sales by Country (2016-2021) & (K Units) Table 31. Latin America Medicine for Osteoarthritis Pain Sales Market Share by Country (2016-2021) Table 32. Latin America Medicine for Osteoarthritis Pain Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Medicine for Osteoarthritis Pain Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Medicine for Osteoarthritis Pain Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Medicine for Osteoarthritis Pain Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Medicine for Osteoarthritis Pain Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Medicine for Osteoarthritis Pain Revenue Market Share by Country (2016-2021) Table 38. Global Medicine for Osteoarthritis Pain Sales (K Units) by Type (2016-2021) Table 39. Global Medicine for Osteoarthritis Pain Sales Market Share by Type (2016-2021) Table 40. Global Medicine for Osteoarthritis Pain Revenue (Million US$) by Type (2016-2021) Table 41. Global Medicine for Osteoarthritis Pain Revenue Share by Type (2016-2021) Table 42. Global Medicine for Osteoarthritis Pain Price (USD/Unit) by Type (2016-2021) Table 43. Global Medicine for Osteoarthritis Pain Sales (K Units) by Application (2016-2021) Table 44. Global Medicine for Osteoarthritis Pain Sales Market Share by Application (2016-2021) Table 45. Global Medicine for Osteoarthritis Pain Revenue (Million US$) by Application (2016-2021) Table 46. Global Medicine for Osteoarthritis Pain Revenue Share by Application (2016-2021) Table 47. Global Medicine for Osteoarthritis Pain Price (USD/Unit) by Application (2016-2021) Table 48. Pfizer Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Pfizer Medicine for Osteoarthritis Pain Product Table 52. Pfizer Recent Developments/Updates Table 53. Johnson and Johnson Corporation Information Table 54. Johnson and Johnson Description and Business Overview Table 55. Johnson and Johnson Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Johnson and Johnson Medicine for Osteoarthritis Pain Product Table 57. Johnson and Johnson Recent Developments/Updates Table 58. GlaxoSmithKline Corporation Information Table 59. GlaxoSmithKline Description and Business Overview Table 60. GlaxoSmithKline Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. GlaxoSmithKline Medicine for Osteoarthritis Pain Product Table 62. GlaxoSmithKline Recent Developments/Updates Table 63. Bayer Corporation Information Table 64. Bayer Description and Business Overview Table 65. Bayer Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Bayer Medicine for Osteoarthritis Pain Product Table 67. Bayer Recent Developments/Updates Table 68. Eli Lilly Corporation Information Table 69. Eli Lilly Description and Business Overview Table 70. Eli Lilly Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Eli Lilly Medicine for Osteoarthritis Pain Product Table 72. Eli Lilly Recent Developments/Updates Table 73. Novartis Corporation Information Table 74. Novartis Description and Business Overview Table 75. Novartis Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Novartis Medicine for Osteoarthritis Pain Product Table 77. Novartis Recent Developments/Updates Table 78. Sanofi Corporation Information Table 79. Sanofi Description and Business Overview Table 80. Sanofi Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Sanofi Medicine for Osteoarthritis Pain Product Table 82. Sanofi Recent Developments/Updates Table 83. Horizon Pharma Corporation Information Table 84. Horizon Pharma Description and Business Overview Table 85. Horizon Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Horizon Pharma Medicine for Osteoarthritis Pain Product Table 87. Horizon Pharma Recent Developments/Updates Table 88. Abbott Corporation Information Table 89. Abbott Description and Business Overview Table 90. Abbott Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Abbott Medicine for Osteoarthritis Pain Product Table 92. Abbott Recent Developments/Updates Table 93. Mylan Corporation Information Table 94. Mylan Description and Business Overview Table 95. Mylan Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Mylan Medicine for Osteoarthritis Pain Product Table 97. Mylan Recent Developments/Updates Table 98. Daiichi Sankyo Corporation Information Table 99. Daiichi Sankyo Description and Business Overview Table 100. Daiichi Sankyo Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Daiichi Sankyo Medicine for Osteoarthritis Pain Product Table 102. Daiichi Sankyo Recent Developments/Updates Table 103. TEVA Corporation Information Table 104. TEVA Description and Business Overview Table 105. TEVA Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. TEVA Medicine for Osteoarthritis Pain Product Table 107. TEVA Recent Developments/Updates Table 108. Almatica Pharma Corporation Information Table 109. Almatica Pharma Description and Business Overview Table 110. Almatica Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 111. Almatica Pharma Medicine for Osteoarthritis Pain Product Table 112. Almatica Pharma Recent Developments/Updates Table 113. Astellas Pharma Corporation Information Table 114. Astellas Pharma Description and Business Overview Table 115. Astellas Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 116. Astellas Pharma Medicine for Osteoarthritis Pain Product Table 117. Astellas Pharma Recent Developments/Updates Table 118. Tide Pharmaceutical Corporation Information Table 119. Tide Pharmaceutical Description and Business Overview Table 120. Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 121. Tide Pharmaceutical Medicine for Osteoarthritis Pain Product Table 122. Tide Pharmaceutical Recent Developments/Updates Table 123. Iroko Pharmaceuticals Corporation Information Table 124. Iroko Pharmaceuticals Description and Business Overview Table 125. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 126. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product Table 127. Iroko Pharmaceuticals Recent Developments/Updates Table 128. Hengrui Pharmaceutical Corporation Information Table 129. Hengrui Pharmaceutical Description and Business Overview Table 130. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 131. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product Table 132. Hengrui Pharmaceutical Recent Developments/Updates Table 133. Abiogen Pharma Corporation Information Table 134. Abiogen Pharma Description and Business Overview Table 135. Abiogen Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 136. Abiogen Pharma Medicine for Osteoarthritis Pain Product Table 137. Abiogen Pharma Recent Developments/Updates Table 138. Production Base and Market Concentration Rate of Raw Material Table 139. Key Suppliers of Raw Materials Table 140. Medicine for Osteoarthritis Pain Distributors List Table 141. Medicine for Osteoarthritis Pain Customers List Table 142. Medicine for Osteoarthritis Pain Market Trends Table 143. Medicine for Osteoarthritis Pain Growth Drivers Table 144. Medicine for Osteoarthritis Pain Market Challenges Table 145. Medicine for Osteoarthritis Pain Market Restraints Table 146. Global Medicine for Osteoarthritis Pain Sales Forecast by Type (2022-2027) & (K Units) Table 147. Global Medicine for Osteoarthritis Pain Sales Market Share Forecast by Type (2022-2027) Table 148. Global Medicine for Osteoarthritis Pain Revenue Forecast by Type (2022-2027) & (US$ Million) Table 149. Global Medicine for Osteoarthritis Pain Revenue Market Share Forecast by Type (2022-2027) Table 150. Global Medicine for Osteoarthritis Pain Sales Forecast by Application (2022-2027) & (K Units) Table 151. Global Medicine for Osteoarthritis Pain Sales Market Share Forecast by Application (2022-2027) Table 152. Global Medicine for Osteoarthritis Pain Revenue Forecast by Application (2022-2027) & (US$ Million) Table 153. Global Medicine for Osteoarthritis Pain Revenue Market Share Forecast by Application (2022-2027) Table 154. Global Medicine for Osteoarthritis Pain Sales Forecast by Region (2022-2027) & (K Units) Table 155. Global Medicine for Osteoarthritis Pain Sales Market Share Forecast by Region (2022-2027) Table 156. Global Medicine for Osteoarthritis Pain Revenue Forecast by Region (2022-2027) & (US$ Million) Table 157. Global Medicine for Osteoarthritis Pain Revenue Market Share Forecast by Region (2022-2027) Table 158. Research Programs/Design for This Report Table 159. Key Data Information from Secondary Sources Table 160. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Medicine for Osteoarthritis Pain Figure 2. Global Medicine for Osteoarthritis Pain Market Share by Type in 2020 & 2027 Figure 3. Oral Product Picture Figure 4. Injection Product Picture Figure 5. External Product Picture Figure 6. Global Medicine for Osteoarthritis Pain Market Share by Application in 2020 & 2027 Figure 7. Medical Care Figure 8. Personal Care Figure 9. Global Medicine for Osteoarthritis Pain Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Medicine for Osteoarthritis Pain Market Size 2016-2027 (US$ Million) Figure 11. Global Medicine for Osteoarthritis Pain Sales 2016-2027 (K Units) Figure 12. Global Medicine for Osteoarthritis Pain Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Medicine for Osteoarthritis Pain Sales Share by Manufacturers in 2020 Figure 14. Global Medicine for Osteoarthritis Pain Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Medicine for Osteoarthritis Pain Players: Market Share by Revenue in 2020 Figure 16. Medicine for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Medicine for Osteoarthritis Pain Sales Market Share by Region (2016-2021) Figure 18. Global Medicine for Osteoarthritis Pain Sales Market Share by Region in 2020 Figure 19. Global Medicine for Osteoarthritis Pain Revenue Market Share by Region (2016-2021) Figure 20. Global Medicine for Osteoarthritis Pain Revenue Market Share by Region in 2020 Figure 21. U.S. Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. UAE Medicine for Osteoarthritis Pain Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Medicine for Osteoarthritis Pain by Type (2016-2021) Figure 46. Sales Market Share of Medicine for Osteoarthritis Pain by Application (2016-2021) Figure 47. Sales Market Share of Medicine for Osteoarthritis Pain by Application in 2020 Figure 48. Revenue Share of Medicine for Osteoarthritis Pain by Application (2016-2021) Figure 49. Revenue Share of Medicine for Osteoarthritis Pain by Application in 2020 Figure 50. Manufacturing Cost Structure of Medicine for Osteoarthritis Pain Figure 51. Manufacturing Process Analysis of Medicine for Osteoarthritis Pain Figure 52. Medicine for Osteoarthritis Pain Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Pfizer Johnson and Johnson GlaxoSmithKline Bayer Eli Lilly Novartis Sanofi Horizon Pharma Abbott Mylan Daiichi Sankyo TEVA Almatica Pharma Astellas Pharma Tide Pharmaceutical Iroko Pharmaceuticals Hengrui Pharmaceutical Abiogen Pharma